Intravenous human immunoglobulin (pH4) (Wuhan Ruide)
静注人免疫球蛋白 (pH4)（武汉瑞德）
Report date: 2023/01/02 17:06:14
Base Information
Drug NameIntravenous human immunoglobulin (pH4) (Wuhan Ruide)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesWuhan Ruide Biology Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesWuhan Ruide Biology Products Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A